Pharma Journalist - Page 203 of 924 -

Roche Acquires PathAI to Expand Digital Pathology Business

Altasciences, Certara Partner to Speed Early Drug Development

Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal

Aldeyra Therapeutics Submits New Drug Application to the FDA for Reproxalap for the Treatment of Signs and Symptoms of Dry Eye Disease

Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy

City of Hope scientists develop new potential treatment for brain tumors

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy for the Treatment of HIV in Pediatric Populations

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

C4XD signs exclusive global licence worth up to $402 million with AstraZeneca for the development and commercialisation of NRF2 Activator programme

Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline

Exploring the Implementation of Complex In-vitro Models for Drug Development